Document is current
Any future updates will be listed below
-
Authors
Herron, Jeffrey http://orcid.org/0000-0002-9813-0094
Kremen, Vaclav
Simeral, John D.
Dawes, Heather
Worrell, Gregory A. http://orcid.org/0000-0003-2916-0553
Starr, Philip A. http://orcid.org/0000-0003-2733-4003
Denison, Timothy
Borton, David http://orcid.org/0000-0003-0710-3005
- License Information
-
More Information
Article History
First Online: 22 April 2024
Competing interests
: J.H. and T.D. were previously employed by Medtronic and were involved in the development of the Medtronic Activa PC+S (T.D.) and the Medtronic Summit RC+S (J.H. and T.D.). P.S. has received investigational devices, at no charge, from Medtronic, receives support for clinical fellowship training from Medtronic and Boston Scientific, and is compensated by Neuralink for time serving on the Data Safety and Monitoring Board for the Neuralink PRIME study. G.A.W. has licensed neuromodulation intellectual property to Cadence Neuroscience and has received Medtronic investigational devices free of charge as part of the NIH Brain Initiative. T.D. is a board member of Cortec Neuro, is a co-founder and non-executive chair of Mint Neuro, is a co-founder and director of Amber Therapeutics, and was a co-organizer for the United States National Academies meeting on advancing the adoption of brain stimulation devices. V.K., H.D., J.S. and D.B. declare no competing interests.
